Approval · Notice of Compliance 387 · 2002
EUMOVATE: Notice of Compliance 387
Issued February 19, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 387
- Date
- February 19, 2002
- Company
- Glaxosmithkline Consumer Healthcare UlcMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Topical corticosteroid
Products in this notice
Medicinal ingredients
- CLOBETASONE BUTYRATE 0.05 PER